112 related articles for article (PubMed ID: 7059425)
1. Verapamil bioavailability and dosage in liver disease.
Woodcock BG; Rietbrock N
Br J Clin Pharmacol; 1982 Feb; 13(2):240-1. PubMed ID: 7059425
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.
Somogyi A; Albrecht M; Kliems G; Schäfer K; Eichelbaum M
Br J Clin Pharmacol; 1981 Jul; 12(1):51-60. PubMed ID: 7248141
[TBL] [Abstract][Full Text] [Related]
3. [Drugs with first-pass elimination. Verapamil and dihydroergotamine alkaloids].
Rietbrock N; Woodcock BG
Internist (Berl); 1982 Nov; 23(11):610-5. PubMed ID: 6759451
[No Abstract] [Full Text] [Related]
4. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
Chen M; Xu D; Hu XL; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
[TBL] [Abstract][Full Text] [Related]
5. The bioavailability of a slow-release verapamil formulation.
Norris RJ; Muirhead DC; Christie RB; Devane JG; Bottini PB
Br J Clin Pract Suppl; 1985 Jun; 42():9-16. PubMed ID: 3929828
[No Abstract] [Full Text] [Related]
6. Drug input rate from the GI-tract. Michaelis-Menten kinetics and the bioavailability of slow release verapamil and nifedipine.
Woodcock BG; Menke G; Fischer A; Köhne H; Rietbrock N
Drug Des Deliv; 1988 May; 2(4):299-310. PubMed ID: 3255321
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of verapamil.
Hamann SR; Blouin RA; McAllister RG
Clin Pharmacokinet; 1984; 9(1):26-41. PubMed ID: 6362951
[TBL] [Abstract][Full Text] [Related]
8. Verapamil disposition in liver disease and intensive-care patients: kinetics, clearance, and apparent blood flow relationships.
Woodcock BG; Rietbrock I; Vöhringer HF; Rietbrock N
Clin Pharmacol Ther; 1981 Jan; 29(1):27-34. PubMed ID: 7460471
[TBL] [Abstract][Full Text] [Related]
9. [Drug metabolism in patients with liver disease (author's transl)].
Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
[TBL] [Abstract][Full Text] [Related]
10. Physiological disposition of verapamil in man.
Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
[TBL] [Abstract][Full Text] [Related]
11. [Clinical pharmacology of calcium antagonists].
Lauterburg BH
Schweiz Med Wochenschr; 1987 Mar; 117(13):496-501. PubMed ID: 3576161
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic comparison of oral and intravenous verapamil in atrial fibrillation.
Follath F; Fromer M; Meier P; Vozeh S
Clin Invest Med; 1980; 3(1-2):49-52. PubMed ID: 7009004
[No Abstract] [Full Text] [Related]
13. Application of stable labelled drugs in clinical pharmacokinetic investigations.
Eichelbaum M; von Unruh GE; Somogyi A
Clin Pharmacokinet; 1982; 7(6):490-507. PubMed ID: 6819104
[No Abstract] [Full Text] [Related]
14. Clinical pharmacokinetics of calcium ion antagonists.
Eichelbaum M
Clin Invest Med; 1980; 3(1-2):13-7. PubMed ID: 7471537
[No Abstract] [Full Text] [Related]
15. Calcium antagonists. Pharmacokinetic properties.
Kates RE
Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
Fromm MF; Busse D; Kroemer HK; Eichelbaum M
Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
[TBL] [Abstract][Full Text] [Related]
17. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.
Asthana OP; Woodcock BG; Wenchel M; Frömming KH; Schwabe L; Rietbrock N
Arzneimittelforschung; 1984; 34(4):498-502. PubMed ID: 6540109
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.
Eichelbaum M; Mikus G; Vogelgesang B
Br J Clin Pharmacol; 1984 Apr; 17(4):453-8. PubMed ID: 6721991
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of sustained-release verapamil after a single administration and at steady state.
Mattila J; Mäntylä R; Taskinen J; Männistö P
Eur J Drug Metab Pharmacokinet; 1985; 10(2):133-8. PubMed ID: 3840089
[TBL] [Abstract][Full Text] [Related]
20. Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and response.
Eichelbaum M; Albrecht M; Kliems G; Schäfer K; Somogyi A
Br J Clin Pharmacol; 1980 Nov; 10(5):527-30. PubMed ID: 7437267
[No Abstract] [Full Text] [Related]
[Next] [New Search]
